phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

The second installment of the Patient Experience Survey finds insurer-imposed practices pose significant barriers for Americans as they attempt to access the care they need – and that they are paying for each month in premiums.

Currently, 49% of insured Americans who take prescription medicines report facing barriers such as prior authorization and fail first in the past three months. Prior authorization requires patients to receive approval before their insurer will cover the medicine their doctor prescribed. Step therapy, also known as “fail first,” requires patients to try and fail on one or more medicines before their insurer will cover the medicine originally prescribed. These insurance barriers, among others, not only stand between patients and the medicines they need, but according to our recent findings, are disproportionately imposed on underserved patient populations, including: communities of color and those with mental health conditions. Here are three things you should know:

1. Many Americans face insurance barriers when trying to access their medicines. Roughly half (49%) of insured patients who take prescription medicines report facing at least one of these practices (including prior authorization, fail first, exclusion from a formulary, among others) in the past three months, which may have delayed or limited timely access to their medicines.

pes1

2. The barriers imposed by insurance companies disproportionately affect communities of color and those with mental health conditions. Nearly two thirds (64%) of Hispanic Americans and more than half (55%) of Black Americans who use prescription medicines report experiencing insurance barriers, compared to 44% of white Americans. Patients with mental health conditions also report being disproportionately burdened by access barriers, compared to all Americans using prescription medicines (65% vs. 49%, respectively).

pes2

3. Insurer-imposed practices that limit access to prescription medicines can contribute to non-adherence and may lead to poor health outcomes. A patient’s experience with insurance practices like prior authorization and fail first may exacerbate challenges with their health; 75% of patients who reported non-adherence (not taking medicines as prescribed) were subject to at least one insurance barrier. And those unable to take a medicine as prescribed often report worse health outcomes. Almost half (48%) of those reporting medication non-adherence say their health suffered as a result.

For too many Americans, insurance isn’t working like it should. Read more on the patient experience from the first Patient Experience Survey here. To learn more about PhRMA’s patient-centered solutions, visit PhRMA.org/BetterWay.

For topline results, click here.

Cynthia Hicks

Cynthia Hicks is Senior Director of Public Affairs at PhRMA focusing on polling and opinion research that supports advocacy communications and strategy. Prior to joining PhRMA, Cynthia worked as a consultant, marketer, and head of polling for a civic technology company where her work supported issue advocacy organizations and policy makers on both sides of the aisle. Cynthia is a proud Los Angeles native and outside of the office she enjoys an early morning HIIT workout and spending time with friends and family.

Cynthia Hicks

Survey confirms too many insured Americans face barriers to reliable health care

April 22, 2026

Insurers routinely block seniors’ access to medicines in Medicare Part D

March 18, 2026

Americans believe U.S. pharma leadership needs to be protected

February 26, 2026

50-state poll says Americans are concerned that hospital markups hurt patients

January 27, 2026

"The patient experience: Insurance barriers continue to impede access to health care, especially among the country’s underserved"

Health Insurance

Out-of-Pocket Costs

Polling

The patient experience: Insurance barriers continue to impede access to health care, especially among the country’s underserved

February 28, 2022

"The patient experience: Insurance barriers continue to impede access to health care, especially among the country’s underserved"

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list